Invenomic Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CIVI
Civitas Resources
CIVI
|
+$3.77M |
| 2 |
Centene
CNC
|
+$3.66M |
| 3 |
Dine Brands
DIN
|
+$3.44M |
| 4 |
Lockheed Martin
LMT
|
+$3.21M |
| 5 |
FirstEnergy
FE
|
+$2.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HSII
Heidrick & Struggles
HSII
|
+$4.62M |
| 2 |
CHL
China Mobile Limited
CHL
|
+$4.42M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$3.37M |
| 4 |
MIK
Michaels Stores, Inc
MIK
|
+$3M |
| 5 |
Tanger
SKT
|
+$2.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 7.42% |
| 2 | Financials | 6.92% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Materials | 5.99% |
| 5 | Healthcare | 4.68% |
Similar funds
Invenomic Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Invenomic Capital Management held 175 positions worth $448M, up 14% from $392M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Invenomic Capital Management deployed $34.8M of net new capital in Q1 2021, opening 33 new positions and adding to 39 existing holdings. Its largest new stake was Centene: 59,072 shares worth $3.78M.
By sector, the portfolio is most concentrated in Industrials at 7.4% of assets, up from 6.8% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Discovery, Inc. Series C Common Stock, an estimated $3.37M trimmed.
- Invenomic Capital Management's largest Q1 2021 buy was Centene: 59,072 shares worth $3.78M.
- Invenomic Capital Management added most to Civitas Resources in Q1 2021, an estimated $3.77M increase.
- Invenomic Capital Management's biggest Q1 2021 reduction was Discovery, Inc. Series C Common Stock, cutting an estimated $3.37M.
- Invenomic Capital Management fully exited Heidrick & Struggles in Q1 2021, selling an estimated $4.62M.
- Invenomic Capital Management's ten largest holdings make up 58% of its $448M portfolio in Q1 2021.
- Invenomic Capital Management opened 33 new positions and closed 56 in Q1 2021.
- Invenomic Capital Management's portfolio value rose 14% quarter-over-quarter to $448M.
Based on Invenomic Capital Management's 13F filing for Q1 2021, filed 13 May 2021.